Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial

Hou, YP; Mao, XY; Wang, C; Xu, ZH; Bu, ZH; Xu, M; Li, B

Li, B (通讯作者),Harbin Med Univ, Dept Nephrol, Affiliated Hosp 2, 246 Xuefu Rd, Harbin 150086, Peoples R China.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022; 121 (2): 529

Abstract

Background/purpose: Roxadustat, a first-in-class hypoxia-inducible factor prolyl hydroxylase inhibitor, promotes erythropoiesis and regulates iron met......

Full Text Link